What's going on with Recursion? Cramer stated on Mad Money at the end of last week's trading that Recursion's stock performance has "been disastrous" since the company's management appeared on his ...
That brings us to Recursion Pharmaceuticals (RXRX 3.62%), a biotech company specializing in drug discovery using artificial intelligence (AI). At least one notable name in the investing world thinks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results